This is the authors' abstract. We don't add key points for this paper.
Several types of neuroreceptors are of interest with respect to antipsychotic activity, in particular the D2, D1, and 5-HT2receptors. Among currently prescribed antipsychotic drugs, some have an affinity for a broad range of neuroreceptors, while others are more selective for the D2receptor (Hytellet al, 1985). The most widely accepted hypothesis of neuroleptic drug action is that antipsychotic effects are mediated by a blockade of the dopamine receptors (Carlsson & Lindqvist, 1963; van Rossum, 1966; Creeseet al, 1976; Seemanet al, 1976; Peroutka & Snyder, 1980). This hypothesis has been supported by consistent findings of high D2receptor occupancy in positron emission tomography (PET) studies of patients treated with antipsychotic drugs (Fardeet al, 1986; Smithet al, 1988; Baronet al, 1989). At the same time, the risk of extrapyramidal side-effects (EPS) seems particularly high in patients with occupancy above 80% (Fardeet al, 1992) (Fig. 1).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Nyberg et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: